Předmětem práce posudkového lékaře na Okresní správě sociálního zabezpečení (OSSZ) je posuzování zdravotního stavu klienta v oblasti nemocenského a důchodového pojištění, tzv. pojistný systém. Posudkový lékař OSSZ posuzuje rovněž zdravotní stav klientů pro účely poskytování dávek v tzv. nepojistném systému, zadavatel je Úřad práce, klient žádá tam. Jedná se o příspěvek na péči, kde se posuzuje stupeň závislosti (I. až IV. stupeň), dále průkaz osoby se zdravotním postižením a příspěvek na zvláštní pomůcky.
The main duty of a health assessment doctor at the District Social Security Administration (OSSZ) is to assess the health status of the client in the sector of sickness and pension insurance, i. e., in the insurance scheme. A health assessment doctor at the OSSZ can also assess the health status of the client for the purpose of providing benefits in the non-insurance scheme, with the contracting authority being the employment office and the client applying therein. This includes care allowance, where the degree of dependency (degrees I to IV) is assessed, as well as disability card and special aid allowance.
PURPOSE: To test the effect of race/ethnicity on Social Security Administration (SSA) life tables' life expectancy (LE) predictions in localized prostate cancer (PCa) patients treated with either radical prostatectomy (RP) or external beam radiotherapy (EBRT). We hypothesized that LE will be affected by race/ethnicity. PATIENTS AND METHODS: We relied on the 2004-2006 Surveillance, Epidemiology, and End Results database to identify D'Amico intermediate- and high-risk PCa patients treated with either RP or EBRT. SSA life tables were used to compute 10-year LE predictions and were compared to OS. Stratification was performed according to treatment type (RP/EBRT) and race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic/Latino, and Asian). RESULTS: Of 55,383 assessable patients, 40,490 were non-Hispanic White (RP 49.3% vs. EBRT 50.7%), 7194 non-Hispanic Black (RP 41.3% vs. EBRT 50.7%), 4716 Hispanic/Latino (RP 51.0% vs. EBRT 49.0%) and 2983 were Asian (RP 41.6% vs. EBRT 58.4%). In both RP and EBRT patients, OS exceeded life tables' LE predictions, except for non-Hispanic Blacks. However, in RP patients, the magnitude of the difference was greater than in EBRT. Moreover, in RP patients, OS of non-Hispanic Blacks virtually perfectly followed predicted LE. Conversely, in EBRT patients, the OS of non-Hispanic Black patients was worse than predicted LE. CONCLUSIONS: When comparing SEER-derived observed OS with SSA life table-derived predicted life expectancy, we recorded a survival disadvantage in non-Hispanic Black RP and EBRT patients, which was not the case in the three other races/ethnicities (non-Hispanic Whites, Hispanic/Latinos, and Asians). This discrepancy should ideally be confirmed within different registries, countries, and tumor entities. Furthermore, the source of these discrepant survival outcomes should be investigated and addressed by health care politics.
- MeSH
- Ethnicity MeSH
- Humans MeSH
- Life Expectancy MeSH
- Prostatic Neoplasms * therapy pathology MeSH
- Life Tables MeSH
- United States Social Security Administration * MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- United States MeSH
Úvod: Medikačné pochybenie je definované ako udalosť, ktorá vďaka nevhodnému podaniu medikácie môže spôsobiť alebo môže viesť k poškodeniu pacienta. Táto udalosť je najčastejšie výsledkom ľudského pochybenia, v dôsledku nedbalosti, nedostatku kvalifikácie, nepozornosti, ale je tiež daná počtom príležitostí, pri ktorých môže dôjsť k zlyhaniu. Medikačné pochybenie predstavuje jeden z indikátorov poskytovania kvalitnej a bezpečnej ošetrovateľskej starostlivosti. Cieľ: Cieľom príspevku je poukázať na problematiku medikačného pochybenia v kontexte bezpečnosti pacienta z pohľadu sestry. Metodika: Príspevok predkladá sumarizáciu dostupných informácií v problematike medikačného pochybenia, na príkladoch deklaruje najčastejšie lieky, ktoré sú rizikové z hľadiska zámeny v praxi sestier. Príspevok má charakter literárneho prehľadu. Výsledky: Medikačný omyl, medikačná chyba alebo medikačné pochybenie predstavuje závažný a naliehavý problém najmä z hľadiska bezpečnosti pacienta. Liekové chyby môžu byť klasifikované z rôznych hľadísk. Na základe príčiny, ktorá chybu spôsobila, môžeme hovoriť o vynechaní podania liečiva, ďalej je to podanie chybnej dávky, aplikácia nenaordinovaného lieku, nesprávne zvolená lieková forma, nesprávny čas aplikácie alebo nesprávna cesta podania liečiva. V kontexte s medikačným pochybením sa popisujú aj rizikové lieky k zámene, ktoré sú typické tým, že majú podobný názov alebo ide o rôzne lieky s podobným obalom, či ten istý liek rôzneho objemu, rôznej dávky. V súčasnosti sa pozornosť venuje najmä obmedzovaniu prípravy liekov na oddelení a zaisteniu liekov pripravených k podaniu /RTU – z ang. ready to use/. Ide najmä o koncentrované lieky, ktoré sú dodávané v nosnom roztoku, v koncentrácii umožňujúcej priame podanie do žily. Touto problematikou sa zaoberá aj Svetová zdravotnícka organizácia v spolupráci s Joint Commission International, ktoré vydali smernicu Patient Safety Solutions zameranú na bezpečnosť pri manipulácii s koncentrovanými roztokmi elektrolytov. Ide o medzinárodné štandardy obsahujúce aj štandard pri manipulácii s liekmi s vyššou mierou rizika. Záver: Zvýšenie bezpečnosti procesu podávania liečiv môže byť dosiahnuté elimináciou rizikových faktorov a poskytnutím stratégii na zachytenie chýb a zmiernenie ich následkov. Každá stratégia prevencie chýb musí brať do úvahy celý rad faktorov súvisiacich so zdravotníckym personálom, pacientmi a organizačnými systémami. Zaistiť poskytovanie bezpečnej starostlivosti je jednou z priorít zdravotníctva na všetkých úrovniach. Snahou zdravotníkov by malo byť poskytovanie takej starostlivosti, kde sa riziko chýb eliminuje na čo najnižšiu úroveň.
Introduction: Medication error is defined as an event that, due to the inappropriate administration of medication, may cause or may lead to harm to the patient. This event is most often the result of human error, due to carelessness, lack of qualification, inattention, but it is also given by the number of opportunities in which failure can occur. Medication error is one of the indicators of providing quality and safe nursing care. Objective: The objective of the paper is to highlight the issue of medication error in the context of patient safety from the nurse’s point of view. Methodology: The paper presents a summary of the available information on the issue of medication error, using examples to declare the most common drugs that are risky from the point of view of confusion in the practice of nurses. The contribution has the character of a literary review. Results: Medication error, medication error or medication malpractice represents a serious and urgent problem, especially from the point of view of patient safety. Medication errors can be classified from different points of view. Based on the reason that caused the error, we can talk about missing the administration of the medicine, then it is the administration of the wrong dose, the application of a non-prescribed medicine, the wrongly chosen pharmaceutical form, the wrong time of application or the wrong route of administration of the medicine. In the context of medication error, there are also descriptions of risky medicines for confu- TATIANA HUDÁKOVÁ1,2, MIROSLAVA CAPULIČOVÁ3 1 NsP Trebišov, Svet zdravia, SNP 1079, 075 01 2 SZŠ Michalovce, Masarykova 27, 071 01 3 VÚSCH, Košice, Ondavská 8, 040 11 MEDIKAČNÉ POCHYBENIE A LIEKY RIZIKOVÉ K ZÁMENE MEDICATION MALPRACTICE AND DRUGS AT RISK OF CONFUSION 47 4/2023 sion, which are typical in that they have a similar name or are different medicines with similar packaging, or the same medicine in different volumes, different doses. Currently, attention is paid mainly to limiting the preparation of medicines in the department and securing medicines ready for administration /RTU - from Eng. ready to use/. These are mainly concentrated medicines that are supplied in a carrier solution, in a concentration that allows direct administration into a vein. The World Health Organization also deals with this issue in cooperation with the Joint Commission International, which issued the Patient Safety Solutions directive focused on safety when handling concentrated electrolyte solutions. These are international standards including a standard for the handling of medicines with a higher degree of risk. Conclusion: Increasing the safety of the medication administration process can be achieved by eliminating risk factors and providing a strategy to capture errors and mitigate their consequences. Any error prevention strategy must take into account a range of factors related to healthcare staff, patients and organizational systems. Ensuring the provision of safe care is one of the priorities of healthcare at all levels. The effort of health professionals should be to provide such care where the risk of errors is eliminated to the lowest possible level.
- MeSH
- Patient Safety MeSH
- Medical Errors MeSH
- Medication Errors classification prevention & control MeSH
- Risk Factors MeSH
- Publication type
- Review MeSH
PURPOSE: to compare observed overall survival vs age-adjusted lifetable (LT) derived life expectancy (LE) in metastatic urothelial bladder cancer (MBCa) patients according to race/ethnicity. METHODS: We identified Caucasian, African American, Hispanic/Latino and Asian metastatic urothelial bladder cancer patients from 2004 to 2011 within the Surveillance, Epidemiology and End Results database. Social Security Administration tables were used to compute 5 year LE. LT-derived LE was compared to observed overall survival OS. Additionally, we relied on Poisson regression plots to display cancer-specific mortality (CSM) relative to other-cause mortality (OCM) for each race/ethnicity. RESULTS: Overall, 2286 MBCa patients were identified. Of those, 1800 (79%) were Caucasian vs 212 (9.3%) African American vs 189 (8.3%) Hispanic/Latino vs 85 (3.7%) Asians. The median age at diagnosis was 71 years for Asians vs 70 for Caucasians vs 67 for Hispanic/Latinos vs 67 for African Americans. African Americans showed the biggest difference between observed OS and LT-predicted LE at five years (- 83.8%), followed by Hispanic/Latinos (- 81%), Caucasians (- 77%) and Asian patients (- 69%). In Poisson regression plots, Hispanic/Latinos displayed the highest cancer-specific mortality rate (88%), while African/Americans showed the highest other cause mortality rate (12%). Conversely, Asian patients displayed the lowest CSM rate (83%) and second lowest OCM rate (7%). CONCLUSIONS: African Americans showed the least favorable survival profile in MBCa, despite being youngest at diagnosis. Contrarily, Asians displayed the best survival profile in MBCa, despite being oldest at diagnosis.
- MeSH
- White People MeSH
- Black or African American MeSH
- Ethnicity MeSH
- Carcinoma, Transitional Cell * MeSH
- Humans MeSH
- Life Expectancy MeSH
- Urinary Bladder Neoplasms * MeSH
- SEER Program MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Life expectancy (LE) is an important consideration in the clinical decision-making for T1aN0M0 renal cell cancer (RCC) patients. OBJECTIVE: To test the effect of race/ethnicity (Caucasian, African American, Hispanic/Latino, and Asian) on LE predictions from Social Security Administration (SSA) life tables in male and female T1aN0M0 RCC patients. DESIGN, SETTING, AND PARTICIPANTS: We relied on the Surveillance, Epidemiology, and End Results database. INTERVENTION: Radical nephrectomy (RN) and partial nephrectomy (PN). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Five-year and 10-yr observed overall survival (OS) of pT1aN0M0 RCC patients treated between 2004 and 2006 were compared with the LE predicted from SSA life tables. We repeated the comparison in a more contemporary cohort (2009-2011), with 5-yr follow-up and higher PN rates. RESULTS AND LIMITATIONS: In the 2004-2006 cohort, PN rate was 40.7%. OS followed the predicted LE in Caucasians, Hispanics/Latinos, and Asians, but not in African Americans, in whom 5-yr OS rates were 5.0% (male) and 8.7% (female) and 10-yr rates were 4.2% (male) and 11.1% (female) lower than predicted. In the 2009-2011 cohort, PN rate was 59.4%. Same observations were made for OS versus predicted LE in Caucasians, Hispanics/Latinos, and Asians. In African Americans, 5-yr OS rates were 1.5% (male) and 4.9% (female) lower than predicted. CONCLUSIONS: In RN- or PN-treated pT1aN0M0 RCC patients, LE predictions closely approximated OS of Caucasians, Hispanics/Latinos, and Asians. In African-American patients, SSA life tables overestimated LE, more in females than in males. The limitations of our study are its retrospective nature, its validity for US patients only, and the under-representation of racial/ethnic minorities. PATIENT SUMMARY: Social Security Administration life tables can be used to estimate long-term life expectancy in patients who are surgically treated for renal cancer (≤4 cm). However, while for Caucasians, Hispanics/Latinos, and Asians, the prediction performs well, life expectancy of African Americans is generally overestimated by life table predictions. TAKE HOME MESSAGE: In the clinical decision-making process for T1aN0M0 renal cell cancer patients eligible for radical or partial nephrectomy, the important influence of patient sex and race/ethnicity on life expectancy should be taken into account, when using Social Security Administration life tables.
- MeSH
- Ethnicity MeSH
- Carcinoma, Renal Cell * ethnology pathology surgery MeSH
- Humans MeSH
- Life Expectancy ethnology MeSH
- Kidney Neoplasms * ethnology pathology surgery MeSH
- Nephrectomy methods MeSH
- Retrospective Studies MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Článek přináší informace o možnostech celoživotního vzdělávání lékařů pracujících v lékařské posudkové službě sociálního zabezpečení a predikci možného dalšího vývoje oboru. Autoři zdůrazňují, že se do budoucna lékařská posudková služba (LPS) neobejde bez činnosti nelékařských zdravotnických pracovníků jako asistentů posudkových lékařů na okresních správách sociálního zabezpečení. Autoři se domnívají, že k zachování medicínského oboru posudkové lékařství a zkvalitnění činnosti lékařské posudkové služby bude třeba provést paradigmatické změny v organizaci a činnosti rezortní posudkové služby. Za zásadní považují vyjmutí LPS ze struktur České správy sociálního zabezpečení.
The article provides information about lifelong education of doctors working in Medical Assessment Service of social security system, as well as forecasts possible future development in this field. The authors highlight that the Medical Assessment Service will need paramedics as assistants of the assessing doctors at the District Social Security Administration Offices. Authors consider a paradigm shift in organisation and work of the departmental assessment service necessary to preserve and improve the medical assessment service field. In this regard authors consider to removal of medical assessment service from the structures of Czech Social Security Administration as essential.
- Keywords
- posudkový asistent,
- MeSH
- Physicians MeSH
- Humans MeSH
- Peer Review, Health Care * MeSH
- Disability Evaluation MeSH
- Social Security MeSH
- Check Tag
- Humans MeSH
OBJECTIVES: To quantify the magnitude of differences between observed overall survival and respective, age-adjusted Social Security Administration life tables-derived life expectancy in Caucasian, African American, Hispanic/Latino and Asian metastatic prostate cancer patients. Furthermore, to test for differences in cancer-specific mortality and other-cause mortality according to race/ethnicity. METHODS: We relied on the 2004-2006 Surveillance, Epidemiology and End Results database to identify Caucasian, African American, Hispanic/Latino and Asian metastatic prostate cancer patients. Social Security Administration life tables were used to compute 10-year life expectancy for comparisons with observed overall survival. Poisson regression plots showed cancer-specific mortality relative to other-cause mortality for each race/ethnicity. RESULTS: A total of 2574 (64.2%) patients were Caucasian, 753 (18.8%) were African American, 453 (11.3%) were Hispanic/Latino and 227 (5.7%) were Asian, respectively. The median age at diagnosis was 72 years in Caucasian patients, 68 years in African American patients, 70 years in Hispanic/Latino patients and 72 years in Asian patients. Observed overall survival rates were always lower compared with respective predicted life expectancy. The magnitude of the difference between observed overall survival and predicted life expectancy at 10 years was highest in African American patients (-52.2%), followed by Caucasian patients (-48.3%), Hispanic/Latino patients (-46.1%) and Asian patients (-37.4%). African American patients showed the highest cancer-specific mortality rates (71.1%) and second-highest other-cause mortality rates (17.4% vs highest 18.4% in Caucasian patients), despite having the youngest age at diagnosis. Asian patients showed the lowest cancer-specific mortality rates (65.5%, P < 0.0001) and lowest other-cause mortality rates (13.3%, P = 0.04), despite having the oldest age at diagnosis. CONCLUSIONS: Despite having the youngest age at diagnosis, African American patients show the least favorable survival profile in metastatic prostate cancer. Conversely, Asian patients show the most favorable survival profile in metastatic prostate cancer, despite having the oldest age at diagnosis.
- MeSH
- White People MeSH
- Black or African American MeSH
- Ethnicity * MeSH
- Humans MeSH
- Life Expectancy MeSH
- Prostatic Neoplasms * MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
Východiska: Castlemanova choroba (Castleman disease – CD) je vzácné lymfoproliferativní onemocnění zahrnující unicentrickou a multicentrickou formu, které se dále dělí do čtyř histomorfologických variant (hyalinně-vaskulární, plazmocelulární, smíšené a plazmablastické). Multicentrická CD je typicky agresivní relabující onemocnění s generalizovanou lymfadenopatií a systémovými příznaky. PET/CT po podání 18F-fluorodeoxyglukózy (FDG-PET/CT) je zobrazovací metoda, která je běžně využívána u maligních lymfomů k určení rozsahu postižení a monitorování léčebné odpovědi. Informace o jejím přínosu u Castlemanovy choroby se však v literatuře vyskytují jen okrajově. Soubor pacientů a metody: Do retrospektivní studie bylo zařazeno 29 pacientů (18 mužů a 11 žen) diagnostikovaných v letech 1998–2016. Všichni byli vyšetřeni na FDG-PET/CT pro zjištění rozsahu onemocnění a/nebo v rámci monitorování léčebné odpovědi. Sledován byl maximální příčný rozměr léze a index vyjadřující poměr maximální standardizované hodnoty vychytávání sledované léze a jater. Informace o vyšetřeních, pacientech a rozsahu jejich onemocnění byly uloženy do registru a poté statisticky vyhodnoceny. Výsledky: Unicentrická forma byla zjištěna u 17 pacientů, 12 pacientů mělo multicentrickou formu onemocnění. Medián věku v době diagnózy byl srovnatelný u unicentrické (51 let) a multicentrické (58 let) formy (p = 0,352). Převážná část pacientů s multicentrickou CD (83 %) byli muži. U žen převažovala unicentrická forma onemocnění (82 vs. 18 %), u mužů byly obě formy téměř stejně zastoupené (44 vs. 56 %; p = 0,064). Většina pacientů (88 %) s unicentrickou CD měla hyalinně-vaskulární histomorfologický typ onemocnění, naproti tomu u pacientů s multicentrickou CD převažoval plazmocelulární typ (42 %). Nejčastěji postiženými oblastmi byly retroperitoneum (52 %) a hrudník (43 %). Postižení tříselných uzlin se objevilo pouze u pacientů s multicentrickou CD. U opakovaně vyšetřovaných pacientů prokázalo FDG-PET/CT během účinné léčby postupné zmenšování velikosti zvolené patologické uzliny a postupný pokles její metabolické aktivity. Závěr: FDG-PET/CT je vhodná metoda pro detekci a monitorování průběhu CD, zejména u pacientů s multicentrickou formou onemocnění.
Background: The paper deals with temporary incapacity for work and newly created first, second or third degree disability in people diagnosed with lung cancer (dg. C34). The aim of this study was to describe the economic impacts on the budget in the Czech Republic, spent through the Czech Social Security Administration on temporary incapacity for work and newly created disability pensions due to the disease. For greater completeness of the impact on the budget of the Czech Republic, we have also provided an overview of applications for care allowance and applications for the purpose of granting a disability card. Material and methods: The starting point for the evaluation was the data provided by the Czech Social Security Administration. The basic research group consisted of people with dg. C34, who applied for an invalidity pension in 2016-2019, due to first, second and third degree invalidities. The disability and temporary incapacity for work is therefore related to a group of people at working age. With the help of quantitative research using content analysis of the text, we performed data evaluation. Results: We found that even though the number of people applying for a disability pension for dg. C34 is declining slightly, the expenditure on these pensions is still high. In the years 2016, 2017, 2018 and 2019, the research groups consisted of 612, 631, 576 and 543 people, respectively. Conclusion: The disease associated with lung cancer is not only characterized by high mortality, but is also one of the very common causes of temporary incapacity for work and new disabilities. This fact therefore contributes significantly to the economic costs of the Czech Republic.
Článek analyzuje vývoj invalidity u osob s onemocněním HIV za sledované období 9 let od roku 2010 do roku 2018. Současná kritéria posuzování invalidity byla nastavena v roce 2010 a jsou upravena příslušnými právními předpisy. Příspěvek využívá data České správy sociálního zabezpečení, analyzuje incidenci invalidity z důvodu infekce onemocnění HIV v porovnání s incidencí ostatních onemocnění v populaci České republiky. Autoři přibližují posudková kritéria invalidity na prezentované kazuistice. V závěru doporučují aktualizaci stávajících posudkových kritérií, a to i v souvislosti s implementací MKN-11 v České republice.
The present paper analyses the development of invalidity in people living with HIV over a nine-year period from 2010 to 2018. The disability assessment criteria currently in place were introduced in 2010 and are legally regulated. The paper draws from the Czech Social Security Administration data to analyse the incidence of invalidity as a result of HIV infection compared to other diseases in the Czech population. The authors illustrate the invalidity assessment criteria with a case study. In the final part, updating the current assessment criteria is recommended, also because of the envisaged ICD-11 implementation in the Czech Republic.
- MeSH
- Lymphoma, B-Cell MeSH
- HIV Infections * diagnosis complications MeSH
- Incidence MeSH
- Middle Aged MeSH
- Humans MeSH
- Hearing Loss MeSH
- Disability Evaluation * MeSH
- Legislation, Medical MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Case Reports MeSH
- Geographicals
- Czech Republic MeSH
Úvod: Osoby s psychotickým onemocněním patří mezi skupiny nejvíce ohrožené nezaměstnaností, chudobou a souvisejícími problémy s bydlením. Cílem článku je analyzovat epidemiologickou a socioekonomickou situaci lidí s duševním onemocněním psychotického okruhu v České republice. Metoda: Data byla čerpána z epidemiologické populační studie duševních onemocnění v České republice realizované vroce 2017, databází Ústavu pro zdravotnické informace a statistiku, databází České správy sociálního zabezpečení a kohortové studie lidí užívajících komunitní a lůžkové psychiatrické služby v ČR 2015/2016. Data byla zpracována pomocí deskriptivních a základních analytických statistických metod. Výsledky: V ČR prožívá symptomy psychotických onemocnění více než 150 tisíc lidí, ambulantně se léčí necelých 50 tisíc a v lůžkové péči pak více než 8 tisíc lidí ročně. Nezaměstnanost lidí propuštěných z lůžkové péče přesahuje 82%. Ani hodinu v jakémkoli typu zaměstnání, včetně tréninkových a chráněných míst, nestráví 63 % z lidí čerpajících komunitní psychiatrické služby. V obou těchto skupinách více než 90 % lidí čerpá invalidní důchod, což je současně zdroj jejich nejvyššího příjmu. Přibližně 30 % lidí čerpajících komunitní služby nedosahuje čistého měsíčního příjmu vyššího než 8 500 Kč, příjem vyšší než 12 750 Kč pak nemá ani čtvrtina těchto osob. Rodina poskytuje péči přibližně polovině lidí čerpajících komunitní služby, a to v průměru více než 42 hodin za měsíc. Psychotická onemocnění jsou významnou příčinou nově přiznaných invalidních důchodů a příspěvků na péči. Závěr: Většině lidí s problémy psychotického okruhu se nedostává soustavné odborné pomoci. Ti, kteří pomoc dostávají, mají závažné problémy v sociální oblasti a často žijí pod hranicí chudoby, k čemuž přispívá i současný systém zaměstnávání lidí s duševním onemocněním. Tato situace je neobhajitelná a vykazuje prvky strukturální diskriminace.
Introduction: People with psychosis are one of the most vulnerable groups in terms of unemployment, poverty and housing issues. The aim of this paper is to analyse the epidemiological and socio-economic situation of people with a psychotic disorder in the Czech Republic. Method: The data was gathered from multiple sources including: the epidemiological population study of mental health disorders in the Czech Republic conducted in 2017, registers of Institute of Health Information and Statistics of the Czech Republic, databases of Czech Social Security Administration and a cohort study of people consuming community and inpatient psychiatric services in the Czech Republic conducted in 2015/2016. The data was analysed using descriptive and basic analytical statistical methods. Results: More than 150,000 people in the Czech Republic suffer from psychotic symptoms, from this group less than 50,000 people are treated in an outpatient setting and more than 8,000 people are treated in an inpatient setting annually. The unemployment rate of people with psychotic disorders discharged from hospital setting exceeds 82%. About 63% of people with psychosis who consume community services do not work for at least an hour per month (including sheltered employment). In both groups, more than 90% of people receive a disability pension, which is also the source of their highest income. Approximately 30% of people using community services do not receive more than 8,500 CZK per month. A quarter of this population has an income higher than 12,750 CZK. About half of the people benefiting from community services, also receive family support at the same time. On average, family members provide care for 42 hours per month. Psychotic disorders are a notable cause of newly granted disability pensions and care allowances. Conclusion: Most of the people with psychotic disorders do not receive continuous professional care. Those who do receive care, have severe social problems and live under the poverty level. The system of employment of people with severe mental illness contributes to this situation. This situation is untenable and shows elements of structural discrimination.
- MeSH
- Adult MeSH
- Humans MeSH
- Psychiatric Status Rating Scales MeSH
- Psychotic Disorders * epidemiology complications psychology MeSH
- Social Conditions MeSH
- Social Security organization & administration statistics & numerical data MeSH
- Socioeconomic Factors * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Meta-Analysis MeSH
